Impact of COVID-19 on Placental Health: A Study Overview

Understanding the Placenta’s Role

The placenta is a crucial organ in fetal development, forming first and providing oxygen and nutrients from the mother’s blood to the growing fetus. It also removes carbon dioxide and waste products, acting similarly to lungs for the fetus. Additionally, the placenta anchors the fetus to the uterine wall and influences hormonal changes during pregnancy. Notably, reduced placental function does not always lead to adverse outcomes for the baby, as many infants are born healthy despite these challenges. However, analyzing the placenta’s health post-delivery can offer insights into the baby’s condition during pregnancy.

The Context of COVID-19 in Pregnancy

COVID-19 remains a significant global health concern, with most cases presenting mild symptoms. However, the implications of the virus during pregnancy are still largely unknown. Historical context, such as the increased rates of cardiovascular disease observed in infants during the 1918-1919 influenza pandemic, underscores the need for research in this area. Investigating the effects of COVID-19 on pregnancies is essential to prevent potential negative outcomes.

Study Design and Findings

A recent study published in the American Journal of Clinical Pathology explored how COVID-19 affects the placenta. The study involved 16 women who tested positive for COVID-19 during their pregnancy and delivered between March 18, 2020, and May 5, 2020. Among them, four women tested positive before delivery, while the remainder tested positive at the time of delivery. Notably, five participants exhibited no symptoms.

After delivery, researchers analyzed the placentas for markers such as blood flow and inflammation, comparing these findings with a control group of historical placental examinations from women without COVID-19 during their pregnancies.

Results of the Study

From the study group, there were 16 live births, with 15 healthy babies born in the third trimester; 14 of these infants had normal birth weights. However, one participant experienced a miscarriage in the second trimester, the cause of which remains uncertain. The analysis revealed no significant increase in visible inflammation in the placentas of the study group compared to the control group.

However, placentas from COVID-19 positive patients exhibited higher rates of maternal vascular malperfusion and intervillous thrombi. Maternal vascular malperfusion refers to an abnormality in the placental blood vessels that leads to inadequate blood flow to the fetus, while intervillous thrombi indicates the presence of blood clots within the placenta. Despite these abnormalities, the babies born to infected women were generally healthy.

Conclusion and Future Research Directions

The findings of this study suggest that COVID-19 may negatively impact placental development. While further research is needed to confirm these results, especially given the limited sample size of 16 patients, it is crucial to monitor pregnant women with COVID-19 closely. This study highlights the importance of ongoing research in understanding the implications of COVID-19 on pregnancy and fetal health.

References

Gude, N. M., Roberts, C. T., Kalionis, B., & King, R. G. (2004). Growth and Function of the Normal Human Placenta. Thromb Res, 114(5-6), 397–407. doi: 10.1016/jthromres.2004.06.038

Placentas from COVID-19-positive pregnant women show injury. (2020, May 22). Retrieved May 25, 2020, from https://www.eurekalert.org/pub_releases/2020-05/nu-pfc052220.php

Shanes, E. D., Mithal, L. B., Otero, S., Azad, H. A., Miller, E. S., & Goldstein, J. A. (2020). Placental Pathology in COVID-19. American Journal of Clinical Pathology. doi: 10.1093/ajcp/aqaa089